Latest stories on NMRA
Neumora Ends Navacaprant After Phase 3 Trial Failure
TipRanks53 · neutralgeneral
Neumora Therapeutics, Inc. (NMRA) files 8-K
SEC 8-K50 · neutralgeneral
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update | NMRA Stock News
StockTitan58 · neutralproduct/pr